Background: The wireless motility capsule concurrently measures temperature, pH
| INTRODUCTION
Gastrointestinal (GI) motility can be considered as movements within the digestive system and transit of contents across the absorptive and secretary surface. This process is coordinated and regulated through a complex circuitous interaction between a numbers of system including, but not limited to, the enteric, autonomic and central nervous systems. When aberrancies occur in any of these, it may result in disruption of the coordination of propulsive peristalsis, potentially leading to dysmotility and ultimately symptoms.
1 However, dysmotility has been used to describe a plethora of abnormalities, which are not purely limited to alterations in transit but may also result in changes in GI sensorimotor activity. 2 Currently, our understanding of GI motility, both in health and disease, has been limited by the relative inaccessibility of certain portions of the GI tract. 3 Although several techniques are available to evaluate such regions, many of these primarily measure only transit times, although it is well recognised that these poorly predict symptoms. 4 Technological developments, such as those seen with high-resolution manometric techniques, have facilitated the concurrent evaluation of both motility as well as contractility patterns. 5, 6 While these techniques are considered to be the gold standard, by definition they necessitate the placement of an intraluminal catheter which can cause a transient disturbance in the underlying regulatory neural systems that control motility. 7 Furthermore, particularly for the assessment of large bowel function, studies need to be of relatively long duration (>24 hours), can necessitate colonoscopy and sedation (that may potentially influence motility) and require the subject under study to be confined to the laboratory. 8 Therefore, techniques that measure both contractility and motility that do not require an intraluminal catheter provide an alternative and more attractive method of describing normal and abnormal GI physiology. 5, 9 To be clinically applicable, such techniques should be standardised, reproducible and easily interpretable as well as acceptable to the patient. In this regard, the wireless motility capsule has a number of salient advantages. 10, 11 For instance, it is minimally invasive, ambulatory and does not require exposure to ionising radiation.
Additionally, the wireless motility capsule has been demonstrated to be sensitive and specific technique in measuring pan-enteric and regional transit is comparable to conventional methods and has robust normal ranges for transit times and pH. [11] [12] [13] The wireless motility capsule has been approved for use in the USA by the Food and Drug Administration for investigating suspected delayed gastric emptying and chronic constipation. 14 In addition to measuring temperature and pH, the wireless motility capsule also measures intraluminal pressure as it traverses the GI tract. 10, 14 However, this has received scant attention in the literature to date. Moreover, the inter-observer agreement of contractility measures has not been comprehensively described. 15 The primary aim of this study was to define normative ranges for regional and contractility/motility measures. Our secondary aims were to evaluate the inter-observer agreement between transit times, pH profile and contractility/ motility parameters as well as investigating the co-relationship between these and the motility index.
| MATERIALS AND METHODS

| Study population
The study population consisted of 109 healthy participants who underwent wireless motility capsule testing in studies performed in the UK (14/109), Sweden (22/109) and the USA (73/109). The data from the USA were collected during a multi-centre clinical trial evaluating GI transit as measured by the wireless motility capsule in comparison to radio-opaque markers and has been published elsewhere. 16 The data from Sweden were collected as part of the process for deriving normative transit values. 12 The data from the UK were derived from the baseline recordings in healthy subjects of a clinical trial programme investigating the promotile drug camicinal. 17 The 
| Wireless motility capsule
The wireless motility capsule (SmartPill, Medtronic, Minneapolis, USA) has been described elsewhere. 13, 18 In brief, the wireless motil- 19 In brief, the gastric region and gastric emptying time were defined from capsule ingestion, which is associated with a sharp temperature rise to 37°C, until a steep pH rise (>3 pH units) from gastric baseline to a pH greater than 4.0 pH units, reflecting passage across the pylorus. The small bowel region and small bowel transit time were defined as from this point until passage across the ileocaecal junction (ICJ), characterised a sustained drop in pH greater than 1 pH unit, and sustained for at least 10 minutes. 18 Finally, the colonic region and colonic transit time were defined from this point until capsule expulsion, verified by a characteristic temperature drop from body temperature to room temperature, see Figure 1 .
| Motility and contractility measures
Motility and contractility measures were calculated using 2 pieces of The software calculates log e MI over the segment of interest, ie, gastric, small bowel and colon, as previous studies have suggested that the cumulated slope is linear. 22 The log e MI therefore provides amplitude-based summary measure. GIMS Data viewer has been designed for research use. Pan-enteric data are shown in the Data S1.
| Inter-observer agreement
Inter-observer agreement was assessed in all participants. Traces were independently analysed by 2 observers (ADF and CBH).
| Statistical analysis
The motility/contractility measures are summarised using the number of observations, mean and standard deviation. To evaluate the effect of gender, age and study country on the study endpoints, a multiple linear regression model was used. Reference ranges for the motility parameters were derived from the 5th to 95th percentiles. Agreement between observers was compared using the intra-class correlation coefficient, and Bland-Altman's limits of agreement. A 2-way, random effects, single measure intra-class correlation coefficient model was used and interpreted according to prolonged wireless motility capsule (r = .2, P = .04). The mean gastric, small bowel and colonic pH were 2.4 AE 1.5, 6.9 AE 1 and 6.8 AE 1.1 respectively. No gender, age or country differences were seen.
| Motility/contractility measures-MotiliGI
Motility and contractility measures derived from MotiliGI are shown in Table 1 . Gastric (r = .24, P = .01), small bowel (r = .22, P = .02) and colonic (r = 0.2, P = .04) maximal pressures correlated with age.
The small bowel motility index was higher in females than males (150.4 AE 12 vs 122 AE 7.6, P = .04). No other gender or country differences were evident. As expected based on their calculations, the respective gastric, small bowel and colonic motility indices correlated with the gastric (r = .65, P < .0001), small bowel (r = .6, P < .0001) and colonic (r = .6, P < .0001) mean contraction amplitude. As expected based on their calculations, the gastric, small bowel and colonic MI correlated with their respective gastric (r = .72, P < .0001), small bowel (r = .8, P < .0001) and colonic (r = .5, P < .0001) mean contraction frequency. Gastric emptying time correlated with gastric MI (r = .4, P < .0001). Small bowel transit time and colonic transit time did not correlate with their respective MI.
| Motility/contractility measures-GIMS
Motility and contractility measures derived from GIMS are shown in Table 2 . The number of contractions within a segment positively correlated with gastric emptying time, small bowel transit time and colonic transit time (r s = .36, P < .0001; r s = .64, P < .0001; and r s = .74, P < .0001). The respective AUC correlated with gastric emptying time, small bowel transit time and colonic transit time (r s = .63, P = .0003; r s = .51, P < .0001; and r s = .69, P < .0001). As expected based on their calculations, gastric log e MI correlated with gastric AUC, total contractions, sum of amplitudes and frequency (r = .86 P = .0001; r = .87 P = .0001; r = .88 P = .0001; r = .61 P = .0001 respectively). Gastric emptying time did not correlate with gastric log e MI. Female gender was associated with a higher gastric log e MI (14 AE 1.5 vs 13.2 AE 1.4, P = .002) but there was no association with age or country. As expected based on their calculation, small bowel log e MI correlated with small bowel AUC, total contractions, sum of amplitudes and frequency (r = .84 P = .0001; r = .86 P = .0001; r = .91 P = .0001; r = .69 P = .0001 respectively).
Small bowel transit time did not correlate with small bowel log e MI.
Gender, age or country was not associated with small bowel log e MI.
As expected based on their calculations, colonic log e MI correlated with colonic AUC, total contractions, sum of amplitudes and frequency (r = .72 P = .0001; r = .87 P = .0001; r = .85 P = .0001; r = .35 P = .0003 respectively). Colonic transit time did not correlate with colonic log e MI, and gender, age or country was not associated with colonic log e MI.
T A B L E 1 Normative regional wireless motility capsule motility/contractility data using MotiliGI showing all and gender-specific means, standard deviations, median and 5%-95% percentiles 
| Inter-observer agreement
Inter-observer agreement was assessed all participants, Table 3 .
Intra-class correlation coefficient and limits of agreement showed excellent reproducibility for majority of the measures.
| DISCUSSION
To date, this is the largest and most comprehensive dataset that describes normative regional and motility/contractility parameters using the wireless motility capsule. The wireless motility capsule has become a popular method for measuring transit times due to is minimally invasive nature in an ambulatory setting. However, normative data only exist with regard to only a proportion of the wireless motility capsule's capabilities, ie transit times and regional pH. 12 Despite this, the wireless motility capsule also provides direct measurements of regional motility/contractility measures, which may also be potentially more useful clinically in evaluating GI motility. Nevertheless, these have been largely ignored in the literature to date. In this study, we have shown that the regional log e MI is a particularly useful summary measure of contractility parameters given its robust correlations with other regional measures such as AUC, total contractions, sum of amplitudes and contraction frequency. Log e MI as reported in this study, ie derived from the wireless motility capsule, is numerically similar to that reported using an intraluminal catheter. 21 Furthermore, we demonstrate that many of these parameters have good inter-observer agreement. Notably, it is clear from many of the motility/contractility measures that there is a large variation in the normal ranges presumably reflecting the diversity of "normal" GI tract physiology.
The GI tract is a complex organ, large parts of which are relatively inaccessible, thus making it a challenge to assess in detail. 3 A number of other methods to assess transit times are currently available, such as scintigraphy, 24 radio-opaque markers, 25 the 3-D magnetic transit system, 3 MRI 26 and the wireless motility capsule. 15 However, transit times per se may represent a blunt tool for evaluating GI motility as abnormalities that lead to symptoms can be more subtle. 3 Despite the functionality of the wireless motility capsule to record pressure as it traverses the GI tract, the majority of studies to date have not presented these data, arguably due to at least 3 factors. Firstly, due to the lack of availability of normative data, secondly due to challenges in calculating/extracting these parameters and finally their relevance to symptoms. However, a recent study by
Barshop et al demonstrated that duodenal area under the pressure curve was strongly and reproducibly associated with symptom severity in patients with both idiopathic and diabetic gastroparesis; these findings warrant confirmation in larger more homogenous patient groups. 27 However, based on the normative data we present herein, the values that they report would be within the normative range for this metric, Table 2 . Nevertheless, such detailed measures may provide alternative relevant physiological endpoints in clinical trials as it is well described that transit times are not optimal to correlate with symptoms. 28 A number of techniques have been developed and studied over the last 50 years utilising a variety of free-floating capsule techniques including those containing radiopharmaceuticals and pressure sensors. 29, 30 A more recently developed method is the 3D transit system which, using an electromagnetic capsule, can delineate pan-enteric and regional GI motility 3 . The marked advantage of this system is that the location, velocity and direction of travel of the capsule, relative to the receiver plate, is known at all times. 4 While this is a minimally invasive and ambulatory technique, the interpretation is labour-intensive and has yet to be validated in a large cohort of healthy subjects and remains a research tool. 3 There was little correlation between transit times and other contractility measures. These data suggest that regional contractility and transit times are not inextricably linked as measured using the wireless motility capsule. In a previous study reported by Hasler and colleagues, of 56 healthy controls and 36 constipated subjects, it was demonstrated that colonic pressure activity increased from the proximal to distal colonic segments in all groups. 31 However, when considering those subjects with the most severe slow transit constipation, there was a marked reduction in this increase in pressure activity albeit not associated with transit times.
We have demonstrated that the inter-observer agreement was excellent for the majority of measures. This is in agreement with the report by Rao et al who have previously described the intra-class correlation coefficient for regional and whole gut transit times in 45 traces, composed of 10 healthy participants, 10 patients with gastroparesis and 25 patients with constipation. 32 The authors demonstrated excellent intra-class correlation coefficients between 3 independent observers. However, this study, to the best of our knowledge, has only been published in abstract form and did not encompass other motility/contractility measures derived from the wireless motility capsule. Moreover, intra-class correlation coefficients in isolation cannot provide a complete picture of inter-observer agreement and should be accompanied by other parameters such as limits of agreement, as included in our study. 33 The process of analysing wireless motility capsule traces using
MotiliGI is relatively straightforward as it includes an analysis "wiz- reported by an automated analysis from MotiliGI suggesting that such an analysis is robust for clinical practice. 12, 34 In both of these studies, the agreement between the automated assessment of small bowel transit time was lower than the other transit measures arguably due to the relative difficulty of identification of the ICJ.
This study is not without limitations. In contrast to high-resolution manometry, the absolute interpretation of parameters derived from the wireless motility capsule is limited by the fact that it is currently not possible to detect a wave front, which represents a propulsive peristaltic pattern. Given that the wireless motility capsule is essentially a nonstatic "free-floating" pressure, pH and temperature transducer, the absolute clinical applicability of this normative dataset is limited to luminal pressures and transit times, but cannot detect the actual propagated pressure waves considered to be the primary mechanism for propulsive motility. Therefore, it could be cogently argued that the phasic contractile measurements delineated by the wireless motility capsule do not significantly add to the information of regional transit that can be measured by radio-opaque markers and/or scintigraphy. Although whole gut transit time can be measured with radio-opaque markers, which correlate reasonably well with wireless motility capsule derived transit times, the wireless motility capsule does offer the advantage of providing a regional motility profile, encompassing the entirety of the GI tract in a single ambulatory investigation. 15 In the clinical environment, whether any of these measures robustly and reproducibly associate with symptoms remains to be seen. The current study was undertaken using a standardised test meal, and while this improves external validity with respect to the normative data, no inferences can be made to these values with respect to other meals of differing nutritional content. A further limitation of our study was that we did not control for the individual female's stage of their menstrual cycle as this may influence GI motility. 35 We had previously shown that female gender was associated with longer gastric emptying time, colonic transit time and whole gut transit time, 12 although we did not demonstrate any associations between gender and transit times in this study. The reasons for this difference are unclear. Finally, the mean peak amplitudes were lower than we would have expected in comparison to previously reported stationary catheter studies 36, 37 and may limit the identification of pathologically low amplitudes of contractions, such as what is seen in connective tissue disorders such as scleroderma. 38 In order to address this in future studies, an alternative approach which would be to use maximal amplitudes although further studies in clinical populations are needed.
In summary, this comprehensive analysis of the motility/contractility data provides normative motility/contractility data for the wireless motility capsule. Notably the log e MI provides a summary 
